These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14628252)

  • 1. [Effects of angiotensin II on inflammation mediators in healthy subjects].
    Lottermoser K; Ulrich-Merzenich G; Vetter H; Düsing R
    Dtsch Med Wochenschr; 2003 Nov; 128(47):2470-5. PubMed ID: 14628252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation of the renin-angiotensin system and blood pressure variability in rats].
    Blanc J; Lambert G; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
    Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
    J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM; Palmisano M; Piraino A; Hirschhorn W; Spencer S; Prasad PP; Ortiz M; Lloyd P
    Clin Pharmacol Ther; 1997 Jan; 61(1):35-44. PubMed ID: 9024172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
    Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Haak T; Geiger H; Scheuermann EH
    Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes.
    Willemsen JM; Westerink JW; Dallinga-Thie GM; van Zonneveld AJ; Gaillard CA; Rabelink TJ; de Koning EJ
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):6-12. PubMed ID: 17261957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
    Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
    Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of acute angiotensin II type 1 receptor blockade on the vascular and adrenal response to exogenous angiotensin II in humans.
    Lottermoser K; Unger T; Gohlke P; Vetter H; Düsing R
    Am J Hypertens; 2003 Jun; 16(6):445-52. PubMed ID: 12799092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
    George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
    J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan.
    Daneshtalab N; Lewanczuk RZ; Russell A; Jamali F
    J Clin Pharmacol; 2004 Mar; 44(3):245-52. PubMed ID: 14973301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock.
    Fenhammar J; Andersson A; Frithiof R; Forestier J; Weitzberg E; Sollevi A; Hjelmqvist H
    Acta Anaesthesiol Scand; 2008 Nov; 52(10):1385-93. PubMed ID: 19025532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of valsartan and indapamide on plasma cytokines in essential hypertension.
    Xie QY; Wang YJ; Sun ZL; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):629-34. PubMed ID: 17062919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
    Cargill RI; Struthers AD; Lipworth BJ
    Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.
    Ekholm M; Kahan T; Jörneskog G; Bröijersen A; Wallén NH
    Thromb Res; 2009 May; 124(1):110-5. PubMed ID: 19195683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation.
    Bo Yang ; Chen YD; Li TD; Feng QZ
    J Renin Angiotensin Aldosterone Syst; 2010 Jun; 11(2):119-23. PubMed ID: 20093323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
    Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
    Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the renin-angiotensin system on the sympathetic response induced by the cold pressor test in humans].
    Zavala LE; Cierco M; Gutiérrez A; Garrido MR; Israel A
    Invest Clin; 2007 Jun; 48(2):155-65. PubMed ID: 17598639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.